ABSTRACT We describe the purification to apparent homogeneity of a protein kinase (desigated AUT-PK 85) from adrenocortical carcinoma 494, as evidenced by sodium dodecyl sulfate/polyacrylamide gel electrophoresis. The enzyme binds cyclic AMP (cAMP) and autophosphorylates but does not use histone, casein, or polysomes as substrates in the presence or absence of cAMP. Stoichiometry of phosphate incororation was 0.71 mol/mol of enzyme. The enzyme was found to have a molecular weight of 85,000 based on gel filtration. The protein was composed of polypeptides having the same molecular weight, 42,000, and thus it appears to consist of two subunits of equal size. The enzyme bound two cAMP molecules, indicating that each subunit binds one molecule of cAMP. The homogeneous enzyme did not inhibit the protein kinase activity of the free catalytic subunit of normal adrenal cAMP-dependent protein kinase under conditions such that recombination with the free regulatory subunit occurred. cAMP bound specifically to the enzyme with an apparent dissociation constant (cfKd) of least partly intact in the tumor cell (2, 4-6). Based on the premise that a cAMP-dependent protein kinase (7) is involved in cAMP-activated adrenal steroidogenesis, it was proposed (4-6) that the defect in the tumor may be due to a defect in the cAMP-dependent protein kinase system (for a review, see ref.
free catalytic subunit of normal adrenal cAMP-dependent protein kinase under conditions such that recombination with the free regulatory subunit occurred. cAMP bound specifically to the enzyme with an apparent dissociation constant (cfKd) of 1.2 X 10-&M. Scatchard plot data indicated one type of binding sites for cAMP. The enzyme did not bind adenosine. This novel autophosphorylating, cAMP-binding, protein kinase may be a characteristic of certain adrenal neop asms.
Studies with isolated adrenocortical carcinoma cells (1) , cultured carcinoma cells (2) , and tumor slices (3) have shown that, in contrast to what occurs in the normal adrenal cell, neither corticotropin (ACTH) nor cyclic AMP (cAMP) stimulates the synthesis of corticosterone. It has been further demonstrated that the route (20S)-20-hydroxycholesterol --pregnenolone --progesterone --deoxycorticosterone --corticosterone is at least partly intact in the tumor cell (2, (4) (5) (6) . Based on the premise that a cAMP-dependent protein kinase (7) is involved in cAMP-activated adrenal steroidogenesis, it was proposed (4) (5) (6) that the defect in the tumor may be due to a defect in the cAMP-dependent protein kinase system (for a review, see ref. 8 ). Recently we isolated a crude protein kinase that bound cAMP with a high degree of specificity but was unable to phosphorylate histone in the presence or absence of the nucleotide (9) . These results were in contrast to the cAMP-dependent protein kinase found in the normal adrenal gland, which binds cAMP and catalyzes the phosphorylation of histones (10) . This report deals with the purification to homogeneity and characterization of this enzyme, designated AUT-PK 85.
METHODS
cAMP binding activity was determined as described (11) except that the reaction was terminated with 2 ml of ice-cold 50% saturated ammonium sulfate. After 20 min the precipitate was collected on GF/C filters and washed twice with 2 ml of 15% saturated ammonium sulfate. The filters were dried and assayed for radioactivity. Protein kinase activity was assayed by the incorporation of 32p from ['y-32P]ATP into either histone as exogenous substrate or into the self-phosphorylating enzyme (12) , using GF/C filters to collect the final precipitate.
All assays were performed in duplicate and the data were corrected for background radioactivity determined with the complete reaction mixture without enzyme.
Protein was determined by the method of Lowry et al. (13) or by the fluorescamine assay (14) .
For electrophoresis in a nondenaturing system, polyacrylamide gels were prepared essentially as described (15, 16) with some modification. Denaturing polyacrylamide gels containing 0.1% sodium dodecyl sulfate were prepared by the method of Favre and Laemmli (17) as modified by Engbaek et al. (18) .
RESULTS
Purification. All procedures were carried out at 0-4oC.
Step I: Homogenization and ammonium sulfate precipitation. One hundred grams of adrenal tumor (19) was minced, mixed with 200 ml of 20 mM Tris-HCI, pH 7.5/5 mM 2-mercaptoethanol/0.2 M EDTA (TME buffer), and homogenized in a Waring blender for 2-3 min. The homogenate was centrifuged for 45 min at 30,900 X g and the supernatant was brought to 50% saturation by the addition of solid ammonium sulfate. Approximately 85% of cAMP binding activity remained with the precipitate which was collected by centrifugation at 30,900 X g for 45 min and then dissolved in 10% (wt/vol) glycerol in TME buffer (TMGE buffer) and extensively dialyzed against TMGE buffer. Normal adrenal protein kinase was prepared in a similar fashion.
Step II: DEAE-cellulose chromatography. The dialyzed sample was fractionated on a DEAE-cellulose column with a linear NaCl gradient (0.04-0.25 M), and the fractions were assayed for binding and cAMP-dependent kinase activity (Fig.  1A) . Two distinct cAMP binding peaks were obtained, one eluting at 0.10 M NaCl and the other eluting at 0.17 M NaCl. The latter was used for further purification. No cAMP-dependent kinase activity was detected in any of the column fractions. Earlier studies (9) showed that the cAMP-dependent protein kinase from bovine adrenal cortex elutes at 0.15 M NaCl on DEAE-cellulose chromatography. In this study the normal protein kinase was obtained by step elution of the DEAE-cellulose column with 0.25 M NaCl in TMGE.
Step III: Hydrophobic chromatography. The DEAE-cellulose cAMP-binding peak fractions eluting at 0.17 M NaCl were chromatographed on hexyl-Sepharose (20) , which removed most of the high molecular weight and hydrophilic proteins (Fig. 1B) dissolved in TME buffer, dialyzed against TMGE buffer, and applied to a column (2.5 X 30 cm) of DEAE-cellulose previously equilibrated with TMGE. The column was washed at 70 ml/hr with 1 column vol (150 ml) of the equilibration buffer and eluted with 500 ml of a linear gradient of NaCl (0.04-0.25 M) in the same buffer. Fractions (5 ml) were analyzed for cAMPbinding activity (-), cAMP-dependent kinase activity (-); absorbance at 280 nm (0) was measured. (B) Hexyl-Sepharose. The cAMP-binding peak fractions eluting at 0.17 M NaCl on DEAE-cellulose (AUT-PK 85) were pooled, dialyzed against 5 mM 2-(N-morpholino)-ethanesulfonic acid, pH 6.5/15 mM 2-mercaptoethanol and fractionated on a hexyl-Sepharose column (1 X 25 cm) previously equilibrated with the same buffer. After washing at a flow rate of 15 ml/hr with 2 column vol (40 ml) of this buffer, the enzyme was eluted with a linear NaCl gradient (10-200 mM) in 2-(N-morpholino)-ethanesulfonic acid buffer. Fractions (2.5 ml) were collected and cAMP-binding activity (-) and absorbance at 280 nm (0) were determined.
histones was not detected in any of the cAMP-binding fractions.
Step IV: Affinity chromatography. Complete purification of the tumor enzyme was achieved when the dialyzed enzyme activity from the hydrophobic chromatography was adsorbed to a 10-ml N6-(2-aminoethyl)amino-cAMP-Sepharose column (21) . Neither binding nor kinase activity could be detected in the column effluent.
To remove all impurities, the cAMP-Sepharose resin was washed extensively with TMGE buffer containing 0.1, 0.5, 1.0, and 2.0 M NaCl and the tumor protein kinase was recovered by incubating the resin with 50 ml of 20 mM cAMP in TMGE buffer at room temperature. The extracts were concentrated by adsorption to a 5-ml DEAE-cellulose column followed by a step-off elution with TMGE containing 0.5 M NaCI. The eluate was dialyzed extensively against TMGE buffer, and essentially all bound cAMP was removed when a dialysis bag containing charcoal suspended in TMGE was placed in the final dialysis buffer. Dialysis against storage buffer (TME/50% glycerol/0. 1 M NaCl) resulted in a further 3fold concentration cAMP, the 3H-labeled nucleotide was covalently incorporated by photolysis (22) and the pattern of radioactivity was analyzed ( Fig. 2A) . In the tumor extract, radioactivity was associated with a protein band at 42,000 daltons, confirming the molecular weight and establishing that the protein isolated by affinity chromatography was the cAMP-binding protein kinase. Analysis of the regulatory subunit from the normal adrenal cortex enzyme showed that the label was associated with a protein band at 49,000 daltons (Fig. 2C) (Fig. 4) (Fig. SB) . This was in contrast to the protein kinase from normal adrenal cortex with which neither the regulatory subunit alone was autophosphorylated ( Fig. 5A ) nor could its catalytic subunit phosphorylate the regulatory moiety (data not shown). Fig. 6A shows the time dependence for autophosphorylation of the homogeneous AUT-PK 85. Addition of cAMP had no effect on the rate of phosphorylation or on the amount of 32P incorporated. Stoichiometry of phosphate incorporation was 0.71 mol/mol of the enzyme. When the tumor enzyme was incubated with cAMP in the presence of cAMP-dependent protein kinase inhibitor, no decrease in the rate of phosphorylation depicted in Fig. 6 Reconstitution Studies. To ascertain that the enzyme isolated from the adrenal tumor is not merely a regulatory subunit of a cAMP-dependent protein kinase, reconstitution with the catalytic subunit from the normal adrenal cortex enzyme was attempted. Incubation of the free catalytic subunit with the tumor kinase in the absence and presence of varying concentrations of cAMP had no effect on the amount of 32p incorporated into histones (Fig. 6B) . This indicated that the tumor kinase cannot reconstitute with the catalytic subunit to an inactive holoenzyme. In contrast, the regulatory and catalytic subunits of the normal adrenal enzyme could be readily reconstituted to a cAMP-responsive holoenzyme.
DISCUSSION
To date, only one mode of action of cAMP has been thoroughly elucidated at the molecular level in eukaryotic cells-i.e., the cyclic nucleotide binds to the regulatory subunit of the protein kinase holoenzyme with the simultaneous release of the catalytic subunit (24, 25) . In bacterial cells, the cAMP-binding receptor lacks kinase activity, binds to DNA, and promotes the transcription of mRNA of inducible enzymes (26, 27) . On the other hand, various effects of cAMP on cellular and subcellular processes have been reported. These include: regulation of cell proliferation (28) and synthesis of protein (29) and RNA (30) ; chromosomal puffing (31) ; changes in membrane properties (31, 32) ; and mediation of the activity of various hormones (33 rylate (36) (37) (38) but the process of autophosphorylation, which is supposed to be an intramolecular rather than intermolecular process (39) , requires the presence of intact enzyme (40) . Furthermore, the molecular weights of the regulatory subunits of the autophosphorylating protein kinase-isolated from rat liver and rat uterus have been found to be 54,000, which are quite different from the molecular weight of the tumor enzyme (41) . These studies indicate that the enzyme AUT-PK 85 reported here is distinct from the protein kinase enzyme present in the normal adrenal gland (10) . Several investigators have reported the presence of cAMP receptors without protein kinase activity in eukaryotic cells (42) (43) (44) (45) . These proteins have at least one of the following characteristics. The dissociation constant for cAMP is about 10-7 M (43-45); adenine derivatives compete for the cAMP site (43) (44) (45) ; and specific adenosine binding sites have been described in enzymes from rat and mouse liver (46) . The tumor enzyme described here, however, does not demonstrate any of these properties. Its dissociation constant for cAMP is at least 1 order of magnitude lower, and it does not posses any binding site for adenosine. Sy and Richter (47) have reported the isolation of another cAMP-binding protein from yeast; the molecular weight of this protein is 24,000, the Kd for cAMP is 5 x 10-9 M, and cGMP effectively competes with the cAMP-binding receptor. None of these properties is shared by the tumor enzyme. Therefore, AUT-PK 85 is different from the protein described-by Sy and Richter (47) .
At present, we cannot assign any physiological role to this protein kinase. It is tempting to speculate that the biochemical lesion responsible for the lack of cAMP-activated corticosterone synthesis in the adrenal tumor may be due to the presence of a variant protein kinase enzyme such as reported here.
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